Pure Extracts Submits Dealer’s Licence Application to Health Canada
Under this framework, a company is required to obtain a licence issued by Health Canada in order to conduct various activities with controlled substances.
- Under this framework, a company is required to obtain a licence issued by Health Canada in order to conduct various activities with controlled substances.
- The issued licence dictates activities, conditions, and restrictions for the licence holder depending on licence permissions.
- On September 25, 2020, Pure Extracts was granted its Standard Processing Licence by Health Canada under the Cannabis Act and the Companys stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
- Important factors that could cause actual results to differ materially from the expectations of Pure Extracts include risks detailed from time to time in the filings made by Pure Extracts under securities regulations.